D. Dutcher

发表

Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart.

M. B. Perryman, M. Bristow, A. Robertson, 1998, Circulation.

Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist

M. Pearson, N. Kraut, Rachel Kroe-Barrett, 2020, Molecular Cancer Therapeutics.

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.

D. Scott, P. Iredale, S. Sakya, 2006, Bioorganic & medicinal chemistry letters.

Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.

M. B. Perryman, J. Port, W. Abraham, 1997, Circulation.

776-1 Selective Down-regulation of Angiotensin II AT1 Receptors in Failing Human Heart: Relationship to β1-Receptor Down-regulation

J. Port, M. Bristow, W. Minobe, 1995 .

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

B. Groves, R. Quaife, D. Badesch, 1997, The Journal of clinical investigation.

Cardiac adrenergic receptor effects of carvedilol.

J. Port, T. Yoshikawa, M. Bouvier, 1996, European heart journal.

8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors.

K. Scearce-Levie, G. Vigers, Xingrong Liu, 2014, Journal of medicinal chemistry.

Discovery of 7-tetrahydropyran-2-yl chromans: β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous system.

K. Scearce-Levie, M. Volgraf, G. Vigers, 2014, Journal of medicinal chemistry.

Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species.

G. Vigers, Xingrong Liu, Darin J. Smith, 2013, Journal of medicinal chemistry.

Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype

R. Quaife, W. Abraham, E. Wolfel, 2002, Molecular medicine.

Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies.

L. Frego, Kristopher Truncali, Rachel Kroe-Barrett, 2018, Biochemical and biophysical research communications.

Diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxycycloalkylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against β-secretase-1 (BACE-1)

G. Vigers, Darin J. Smith, Weiru Wang, 2013 .